Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Yonghe Medical Group Co., Ltd. ( (HK:2279) ) has shared an update.
Yonghe Medical Group Co., Ltd. has scheduled a board meeting for 31 March 2026 to review and approve the group’s audited financial results for the year ended 31 December 2025. The board will also consider whether to recommend a final dividend to shareholders and may address other corporate matters at the same meeting.
The announcement confirms the company’s timeline for releasing full-year results, giving investors clarity on when to expect key financial disclosures. The potential consideration of a final dividend will be closely watched by shareholders as a signal of the group’s earnings strength, capital allocation priorities and confidence in its financial position.
More about Yonghe Medical Group Co., Ltd.
Yonghe Medical Group Co., Ltd. is a healthcare company listed in Hong Kong that operates through a group structure comprising the parent company and its subsidiaries. The group is overseen by a board including executive, non-executive and independent non-executive directors, reflecting a typical Hong Kong–listed corporate governance framework.
Average Trading Volume: 232,614
Technical Sentiment Signal: Sell
Current Market Cap: HK$961.6M
For an in-depth examination of 2279 stock, go to TipRanks’ Overview page.